5LU.F SIMRIS ALG AB B

Healthcare Biotechnology Frankfurt Exchange
0.0034 EUR
Close of Nov 11, 2026
0.0002 0.0186
Market cap
EUR 4.59M
P/E
-
P/B
81.31x
ROE
-3,163.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 5LU.F undervalued?

Graham number

The Graham number of SIMRIS ALG AB B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SIMRIS ALG AB B fundamental analysis

No fundamental analysis for SIMRIS ALG AB B yet.

SIMRIS ALG AB B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SIMRIS ALG AB B

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.

Full company profile